Drug Type Small molecule drug |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Idiopathic Pulmonary Fibrosis | Phase 2 | CZ | 05 Sep 2024 | |
Idiopathic Pulmonary Fibrosis | Phase 2 | BE | 05 Sep 2024 | |
Idiopathic Pulmonary Fibrosis | Phase 2 | CA | 05 Sep 2024 | |
Idiopathic Pulmonary Fibrosis | Phase 2 | NZ | 05 Sep 2024 | |
Idiopathic Pulmonary Fibrosis | Phase 2 | ES | 05 Sep 2024 | |
Idiopathic Pulmonary Fibrosis | Phase 2 | IT | 05 Sep 2024 | |
Idiopathic Pulmonary Fibrosis | Phase 2 | NZ | 05 Sep 2024 | |
Idiopathic Pulmonary Fibrosis | Phase 2 | US | 05 Sep 2024 | |
Idiopathic Pulmonary Fibrosis | Phase 2 | BE | 05 Sep 2024 | |
Idiopathic Pulmonary Fibrosis | Phase 2 | BE | 05 Sep 2024 |